Total amount: € 0,00
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index
Online ISSN 1827-1650
Cianci A. 1, Giordano R. 1, Delia A. 2, Grasso E. 3, Amodeo A. 3, De Leo V. 2, Caccamo F. 3
1 Sezione di Ginecologia, Dipartimento di Scienze Microbiologiche e Scienze Ginecologiche, Università degli Studi di Catania, Catania, Italia
2 Dipartimento di Ginecologia e Ostetricia, Università degli Studi di Siena, Siena, Italia
3 Microbiologia dell’infertilità e malattie sessualmente trasmesse, Azienda Policlinico “G. Rodolico”, Catania, Italia
Aim. The aim of this study was to investigate the efficacy of the use of Lactobacillus rhamnosus GR-1 and of Lactobacillus reuteri RC-14 administrated orally in the treatment and prevention of vaginoses and bacterial vaginitis relapses.
Methods. The study enrolled 50 women in good health, aged between 18 and 48 years, with assessed diagnosis of bacterial vaginosis and vaginitis. The women were randomized in two groups: group A comprised 25 patients with bacterial vaginitis and group B comprised 25 patients with vaginosis. Each patient was administered an antibiotic therapy and subsequently a therapy with Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 (Dicoflor Elle, Dicofarm, Roma, Italy) with two tablets daily for 15 days. After one week from the end of the therapy all patients have been controlled by vaginal swab and microscopic analysis of vaginal secretion.
Results. At the end of the study 46 patients had a complete Lactobacilli recolonization, two patients had no colonization and two dropped out. The results showed that 92% of the enrolled patients benefited from the treatment.
Conclusion. The results of the present study shows that Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14, taken orally, were helpful in vaginosis and bacterial vaginitis treatment and in relapse prevention, as they can re-establish the vaginal ecosystem remarkably.